New blood test could help track spread of rare eye cancer
NCT ID NCT01334008
First seen Nov 25, 2025 · Last updated May 23, 2026 · Updated 13 times
Summary
This study involved 40 adults with metastatic choroidal melanoma, a rare eye cancer that has spread. Researchers developed and tested a blood test to detect circulating tumor DNA, which could help monitor the disease without needing a tissue biopsy. The goal was to see if the test works and compare different detection methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA, DIFFUSE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.